Document Detail

Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse.
MedLine Citation:
PMID:  3048493     Owner:  NLM     Status:  MEDLINE    
From 1977 until June 1987, 139 patients with leukemia underwent allogeneic bone marrow transplantation at Huddinge Hospital. Among recipients of HLA identical bone marrow the survival plateau for 30 patients with acute myeloid leukemia in first remission was 71% from 3 to 7 years. Children (n = 11) had a survival of 100% compared with 52% (n = 19) in adults (p = 0.01). Among patients with acute lymphoblastic leukemia in first remission (n = 15) the actuarial 5-year survival was 73% compared with 31% for those (n = 25) in second to fourth remissions. The probability of relapse in these two groups was 9% and 45% respectively (p less than 0.05). Patients with chronic myeloid leukemia in first chronic phase (n = 27) had a survival plateau from 1 to 6 years of 65%. In Cox's multivariate regression analysis, improved survival was associated with grade 0-I acute graft-versus-host disease (GVHD) (p less than 0.0001), HLA-matched siblings (p less than 0.001), recipient age less than 17 years (p = 0.02), first remission and first chronic phase (p = 0.03), cytomegalovirus (CMV) seronegative recipients (p = 0.04) and absence of symptomatic CMV infection (p = 0.04). A decreased risk of relapse was seen in patients with first remission or first chronic phase (p less than 0.001) and in patients with asymptomatic CMV infection (p = 0.03). In multivariate analysis the p values were 0.002 and 0.09 for these two groups respectively. In these patients acute GVHD was the major obstacle to successful outcome.
O Ringdén; B Sundberg; B Lönnqvist; J Tollemar; G Gahrton; B Nilsson
Related Documents :
24496303 - Calr and asxl1 mutations-based molecular prognostication in primary myelofibrosis: an i...
3162333 - Tumor lysis syndrome after steroid therapy for anaphylaxis.
22309963 - Increased expression of cd55 correlates with tumor progression and poor prognosis in na...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Bone marrow transplantation     Volume:  3     ISSN:  0268-3369     ISO Abbreviation:  Bone Marrow Transplant.     Publication Date:  1988 Jul 
Date Detail:
Created Date:  1988-11-18     Completed Date:  1988-11-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8702459     Medline TA:  Bone Marrow Transplant     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  281-90     Citation Subset:  IM    
Department of Clinical Immunology, Karolinska Institute, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Marrow Transplantation*
HLA Antigens / genetics
Leukemia / mortality,  surgery*
Leukemia, Lymphoid / mortality,  therapy
Leukemia, Myeloid, Acute / mortality,  therapy
Regression Analysis
Risk Factors
Reg. No./Substance:
0/HLA Antigens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  T cell depletion in bone marrow transplantation.
Next Document:  Endocrine function after bone marrow transplantation without the use of preparative total body irrad...